FreeTrials & Tribulations Sales Revenues at the Potential Expense of Patient Safety:The Example of You&i April 13, 2018Vol.44 No.15By Mark J. Ratain, Lisa S. Chen, Allen S. Lichter, R. Donald Harvey, Sonali M. Smith, Leonard B. Saltz, William G. Wierda, Varsha V. Gandhi and Michael J. Keating
Drugs & TargetsFree EC expands XGEVA indications for prevention of skeletal events in multiple myeloma April 06, 2018Vol.44 No.14
Drugs & TargetsFree NCI launches resource for specimens and data from clinical trials April 06, 2018Vol.44 No.14
Drugs & TargetsFree Boehringer Ingelheim, OSE collaborate to develop checkpoint inhibitor April 06, 2018Vol.44 No.14
Clinical RoundupFree NIH completes in-depth genomic analysis of 33 cancer types April 06, 2018Vol.44 No.14
Clinical RoundupFree Simultaneous chemo and immunotherapy may be better for some metastatic bladder cancers April 06, 2018Vol.44 No.14
FreeTrials & Tribulations The importance of staging lung cancer consistently and correctly worldwide April 06, 2018Vol.44 No.14By Fred R. Hirsch
FreeIn Brief Fitzpatrick steps down as CancerLinQ CEO; ASCO CMO Schilsky named interim CEO April 06, 2018Vol.44 No.14
